M11 implant (item 270-0411-03-01-F1)
Ended Awarded Last action
- Contract number
- HT942524F0086
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $23,333
Award facts
- Contract value 100% obligated
- $23,332.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- JBSA FT SAM HOUSTON, TX 78234, USA
Award details come from SAM.gov/FPDS.
About this award
Harvard Bioscience Inc., operating through its Data Sciences International division, received a $23,332.50 firm fixed-price call order from the Defense Health Agency on June 25, 2024, for an M11 implant (Item 270-0411-03-01-F1) with an ultimate completion date of August 5, 2024. This call order was issued under a single-award Blanket Purchase Agreement valued at $4.8 million that Harvard Bioscience holds with the Defense Health Agency, which was originally awarded on May 4, 2022, and extends through May 3, 2027. The BPA serves as an indefinite delivery vehicle enabling the Defense Health Agency, Army Medical Command, and other military health system partners to procure specialized biomedical research solutions, including telemetry devices, implantable equipment, pre-implanted research animals, and associated software and services. Performance of this task order will occur at JBSA Fort Sam Houston in San Antonio, Texas.
The M11 implant is a wireless implantable telemetry transmitter device used in preclinical biomedical research to monitor physiological parameters in laboratory animals. Harvard Bioscience, a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, has demonstrated extensive experience as a critical supplier of advanced physiological monitoring technologies and specialized research instrumentation to federal agencies including the National Institutes of Health, Department of Veterans Affairs, Environmental Protection Agency, Food and Drug Administration, and the Department of Agriculture. The Defense Health Agency has issued task orders under this BPA totaling over $1.5 million cumulatively, reflecting the strategic importance of Harvard Bioscience's biomedical solutions to defense and military health sector research initiatives.
Quick answers
Who was awarded contract HT942524F0086?
HT942524F0086 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on June 25, 2024.
How much is contract HT942524F0086 worth?
The government has obligated $23,333 on HT942524F0086.
Is contract HT942524F0086 an order under another contract?
Yes. HT942524F0086 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract HT942524F0086 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award